<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03269734</url>
  </required_header>
  <id_info>
    <org_study_id>NI_RBC_2016_1</org_study_id>
    <nct_id>NCT03269734</nct_id>
  </id_info>
  <brief_title>Evaluation of the Accuracy of the Vessel Navigator Tool for Catheterization of Supra-aortic Vessels - ARCHIBALD</brief_title>
  <acronym>ARCHIBALD</acronym>
  <official_title>Evaluation of the Accuracy of the Vessel Navigator (Philips Healthcare) Tool for Catheterization of Aortic Arch and Supra-aortic Vessels - ARCHIBALD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares the accuracy of fusion imaging (Fusion Roadmap) versus real-time X-ray
      imaging (Roadmap) during catheterization of supra-aortic trunks of in patients with aneurysms
      or arteriovenous malformations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Catheterization of is performed for the diagnosis and treatment of cerebrovascular diseases.
      It is performed under X-ray scopy in frontal incidence with possible variations of the
      angulation of the arch to optimize the visualization of vessels 'origin (brachiocephalic
      trunk, left and right common carotid arteries, subclavian arteries).

      Before the beginning of catheterization, a conventional arterial roadmap with iodine
      injection is usually performed. The Vessel Navigator (VN) developed by Philips allows the use
      of pre-acquired angio-scan or angio-MRI image by superimposing it (X-ray Fusion) on X-ray
      scopy to provide the arterial tracing (Fusion Roadmap).

      An angio-MRI (Philips 3 Tesla MRI) imaging of the aortic arch will be first performed (as
      part of preoperative assessment or systematic follow-up of aneurysms or arteriovenous
      malformations). A first operator will perform the arteriography under the usual conditions
      without using the VN. A second operator will have access to the fusion imaging and will
      assess the accuracy of the coregistration. Snapshots will be taken by the second operator.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2018</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Offset (in mm) between the lateral edge of the opacified artery and that visualized with the fusion imaging.</measure>
    <time_frame>baseline</time_frame>
    <description>Measurement will be performed 1 cm above each ostium. There will be 4 measurements per patient (4 vessels analyzed).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective opinion of the second operator on the aspect of registration to carry out the catheterization (satisfactory or not).</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Vascular Diseases</condition>
  <condition>Cerebrovascular Diseases</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Aortic Aneurysm</condition>
  <condition>Arteriovenous Malformation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with preoperative assessment or systematic follow-up of aneurysms or arteriovenous
        malformations, arterial cervical or intracranial stenosis, head and neck vascular tumors.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preoperative assessment or systematic follow-up of aneurysms or arteriovenous
             malformations, arterial cervical or intracranial stenosis, head and neck vascular
             tumors.

        Exclusion Criteria:

          -  Patients with contraindication to intravenous contrast.

          -  Patients with catheterization of the supra-aortic vessels in an emergency settings
             (Stroke, acute bleeding)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raphaël BLANC, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation ophtalmologique de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurence SALOMON</last_name>
    <phone>01.48.03.64.31</phone>
    <email>lsalomon@for.paris</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Raphaël BLANC, MD</last_name>
    <email>rblanc@for.paris</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fondation Opthalmologique A de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Raphaël BLANC</last_name>
      <email>rblanc@for.paris</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2017</study_first_submitted>
  <study_first_submitted_qc>August 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2017</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vascular Diseases</keyword>
  <keyword>Cerebrovascular Diseases</keyword>
  <keyword>Cardiovascular Diseases</keyword>
  <keyword>Aortic aneurysm</keyword>
  <keyword>Arteriovenous malformations</keyword>
  <keyword>Catheterization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Arteriovenous Malformations</mesh_term>
    <mesh_term>Hemangioma</mesh_term>
    <mesh_term>Cerebrovascular Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

